652 related articles for article (PubMed ID: 10817565)
1. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Sumida T; Nishioka K
Arthritis Rheum; 1999 Mar; 42(3):519-26. PubMed ID: 10088775
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
Bai S; Liu H; Chen KH; Eksarko P; Perlman H; Moore TL; Pope RM
Arthritis Rheum; 2004 Dec; 50(12):3844-55. PubMed ID: 15593196
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis.
Palao G; Santiago B; Galindo M; Payá M; Ramirez JC; Pablos JL
Arthritis Rheum; 2004 Sep; 50(9):2803-10. PubMed ID: 15457448
[TBL] [Abstract][Full Text] [Related]
5. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
6. Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling.
Palao G; Santiago B; Galindo MA; Rullas JN; Alcamí J; Ramirez JC; Pablos JL
Arthritis Rheum; 2006 May; 54(5):1473-81. PubMed ID: 16646028
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis.
Perlman H; Pagliari LJ; Liu H; Koch AE; Haines GK; Pope RM
Arthritis Rheum; 2001 Jan; 44(1):21-30. PubMed ID: 11212162
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes.
Kim WU; Yoo SA; Min SY; Park SH; Koh HS; Song SW; Cho CS
Clin Exp Immunol; 2006 Jun; 144(3):503-11. PubMed ID: 16734620
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.
Ohshima S; Mima T; Sasai M; Nishioka K; Shimizu M; Murata N; Yoshikawa H; Nakanishi K; Suemura M; McCloskey RV; Kishimoto T; Saeki Y
Cytokine; 2000 Mar; 12(3):281-8. PubMed ID: 10704256
[TBL] [Abstract][Full Text] [Related]
10. Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-alpha and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63.
Kuo PL; Huang YT; Chang CH; Chang JK
Int Immunopharmacol; 2006 Jul; 6(7):1167-75. PubMed ID: 16714221
[TBL] [Abstract][Full Text] [Related]
11. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
12. Potential role of HOXD9 in synoviocyte proliferation.
Khoa ND; Nakazawa M; Hasunuma T; Nakajima T; Nakamura H; Kobata T; Nishioka K
Arthritis Rheum; 2001 May; 44(5):1013-21. PubMed ID: 11352232
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
[TBL] [Abstract][Full Text] [Related]
15. Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts.
Itoh K; Hase H; Kojima H; Saotome K; Nishioka K; Kobata T
Rheumatology (Oxford); 2004 Mar; 43(3):277-85. PubMed ID: 14623946
[TBL] [Abstract][Full Text] [Related]
16. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Gene Ther; 2000 Mar; 7(6):527-33. PubMed ID: 10757027
[TBL] [Abstract][Full Text] [Related]
17. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
Poulaki V; Mitsiades N; Romero ME; Tsokos M
Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
[TBL] [Abstract][Full Text] [Related]
18. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts.
Zhang HG; Huang N; Liu D; Bilbao L; Zhang X; Yang P; Zhou T; Curiel DT; Mountz JD
Arthritis Rheum; 2000 May; 43(5):1094-105. PubMed ID: 10817564
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
